In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2.

chlorpheniramine maleate covid-19 nasal spray sars-cov-2 virucidal

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
17 Sep 2020
Historique:
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 24 9 2020
Statut: epublish

Résumé

Background The initial global outbreak of the novel coronavirus disease 2019 (COVID-2019) pandemic, which is responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), shares similarities with the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) and behaves similarly to influenza with a high intranasal viral load. The genome sequence of COVID-19 opened the opportunity for multiple in vitro and clinical trials, but we still do not have a clear path to treatment. Chlorpheniramine maleate (CPM) is a safe and effective antihistamine with potent antiviral activity against various strains of influenza A/B, thus suggesting that CPM has broad antiviral activity. We tested the virucidal potential of CPM in a nasal spray composition currently in development as an anti-allergy medication. Methods The virucidal activity of CPM was tested using viral stock of SARS-CoV-2, USA-WA1/2020 strain in Vero 76 infected cells. The endpoint titer 50% cell culture infection dose (CCID

Identifiants

pubmed: 32963923
doi: 10.7759/cureus.10501
pmc: PMC7500730
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10501

Informations de copyright

Copyright © 2020, Westover et al.

Déclaration de conflit d'intérêts

Dr. Ferrer has a patent pending for the intranasal formulation with chlorpheniramine.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Biopharm Drug Dispos. 1997 May;18(4):335-46
pubmed: 9158881
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):77-81
pubmed: 9692161
Front Microbiol. 2018 Nov 06;9:2643
pubmed: 30459739
Br J Dis Chest. 1983 Apr;77(2):113-22
pubmed: 6347231

Auteurs

Jonna B Westover (JB)

Animal, Dairy and Veterinary Sciences, Utah State University, Utah, USA.

Gustavo Ferrer (G)

Pulmonary and Critical Care Medicine, Pulmonary Institute, Aventura, USA.
Pulmonary and Critical Care Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.

Hector Vazquez (H)

Pulmonary and Critical Care Medicine, Pulmonary Institute, Aventura, USA.
Pulmonary and Critical Care Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.

Arian Bethencourt-Mirabal (A)

Pulmonary Critical Care, Aventura Hospital and Medical Center, Miami, USA.

Camille Celeste Go (CC)

Family Medicine, Larkin Hospital Palm Springs Campus, Miami, USA.

Classifications MeSH